Gerresheimer database solution accelerates market launch of new drugs
At Gerresheimer, plastic packaging for solid, liquid, and ophthalmic applications is comprehensively documented in a product database. Customers can use this information for all internal processes, but especially for the registration and approval of new drugs. The white paper lists the relevant data contained in the database and explains the advantages for customers.
Comprehensive documentation of Gerresheimer primary packaging made of plastic
Easy identification of the right solution
Documentation facilitates and accelerates registration and approval of new drugs
Düsseldorf, June 18, 2025. Gerresheimer, an innovative systems and solutions provider and global partner for the pharma and biotech industry, underlines its expertise in selecting the right primary plastic packaging with its database. Thanks to the comprehensive packaging documentation, customers can register new medications more easily and quickly, accelerating the market launch process. The web-based, audit-proof product database contains relevant information and up-to-date documentation of the entire product portfolio. The online product catalog on the Gerresheimer website is based on the product database and facilitates the pre-selection of suitable primary packaging. Access to approval-relevant documentation is only available to Gerresheimer customers.
"With the push of a button, our customers have access to a toolbox with complete documentation of all our products. This simplifies and supports product registration in every country”, says Christian Haas, Vice President Sales Europe Primary Packaging Plastic at Gerresheimer. ”Our database highlights our extensive experience and deep understanding of patient safety and our customers' requirements. It is constantly updated with new content and functionality to meet current and future needs.”
Solution provider for solid, liquid and ophthalmic packaging Gerresheimer is the leading solution provider for plastic packaging for solid, liquid and ophthalmic products. The product range includes the leading brands Duma, Dudek and Triveni for solid dosage forms, PET bottles under the edp brand for liquid dosage forms and products for ophthalmic applications. The broad standard range includes a wide variety of containers and closures, PET bottles, eye droppers, nasal sprays, nebulizers, applicators and accessories, as well as countless customer-specific innovative developments, which also include sustainable solutions made from 100% recycled PET or sugar cane. All these products are comprehensively documented in the product database for registration and approval of new drugs or formulations.
Reduced time to market with audit-proof information From the beginning, the goal of developing the database was to simplify and speed up the registration process for customers by giving them direct online access. All relevant information is kept up to date and includes a revision date for any changes. Customers can exchange the required data with their teams and the respective authorities. Customer-specific files can also be uploaded. Thus, the database supports customers’ internal documentation, testing, and approval processes with all relevant certificates and test results. In addition, a complete overview of all standard products, including full documentation, is available at any time.
Complete documentation simplifies work for many departments In addition to reducing time-to-market through thorough documentation, an increasing number of customer departments are taking advantage of the Gerresheimer product database. The R&D department can access information on the dimensions and properties of the packaging solution for their new products. They can also find regulatory and standard drawings, as well as USP (United States Pharmacopeia) test results such as water vapor and light transmission. The quality department can access descriptions of quality control and the most common types of defects, along with their corresponding AQL (Acceptable Quality Level) values. The approval department can view raw material supplier declarations, declarations of compliance, and information on registrations and certifications. The Purchasing Department can identify packaging solutions for new and existing applications for comparison. The production department can use the database to determine the most suitable packaging for their filling line, including packaging and labeling. The sustainability department can use the database to identify the most sustainable packaging solutions for their applications.
The Gerresheimer online product catalog The online product catalog on the Gerresheimer website is based on the product database and contains information on the entire Primary Packaging Plastic portfolio. It facilitates the pre-selection of suitable primary packaging and can be accessed by customers and interested parties here. Access to the complete and approval-relevant documentation is only available to Gerresheimer customers through their assigned Gerresheimer Sales representative.
All advantages and further information about the product database can be found in this whitepaper.
About Gerresheimer Gerresheimer is an innovative systems and solutions provider and a global partner for the pharma, biotech and cosmetic industries. The Group offers a comprehensive portfolio of drug containment solutions including closures and accessories, as well as drug delivery systems, medical devices and solutions for the health industry. The product range includes digital solutions for therapy support, medication pumps, syringes, pens, auto-injectors and inhalers as well as vials, cartridges, ampoules, tablet containers, infusion, dropper and syrup bottles and more. Gerresheimer ensures the safe delivery and reliable administration of drugs to the patient. Gerresheimer supports its customers with comprehensive services along the value chain and in addressing the growing demand for enhanced sustainability. With over 40 production sites in 16 countries in Europe, America and Asia, Gerresheimer has a global presence and produces locally for regional markets. Together with Bormioli Pharma 2024, the Group generated revenues of around EUR 2.4bn and currently employs around 13,400 people. Gerresheimer AG is listed in the MDAX on the Frankfurt Stock Exchange (ISIN: DE000A0LD6E6).
